『C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy』のカバーアート

C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy

C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy

著者： Annenberg Center for Health Sciences
無料で聴く

The emergence of novel targeted complement inhibitors has created new opportunities to improve the health outcomes for patients with C3 glomerulopathy (C3G). Andrew Bomback, MD, MPH, discusses the contemporary management of patients with C3G, highlighting the disease burden and complement pathway dysregulation. The safety and efficacy of approved targeted complement inhibitors are reviewed, including the importance of long-term monitoring and associated vaccination strategies. Dr. Bomback also shares his thoughts about providing personalized care by an interprofessional care team.Annenberg Center for Health Sciences 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Optimizing Care

    Optimizing Care
    2026/08/29
    • Treatment goals
    • Safety of targeted therapy
    • Interprofessional approach
    続きを読む 一部表示
    4 分
  • Targeted Treatments

    Targeted Treatments
    2026/08/29
    • Foundational therapy
    • Treatment targets
    • Targeted therapies: iptacopan, pegcetacoplan
    • Benefits of targeted therapy
    続きを読む 一部表示
    8 分
  • Diagnosis

    Diagnosis
    2026/08/29
    • Clinical features
    • Laboratory assessment
    • Kidney biopsy
    • Additional assessment
    続きを読む 一部表示
    6 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません